137 related articles for article (PubMed ID: 25510801)
1. Grade II gliomas-not so low grade.
Shonka NA
Oncology (Williston Park); 2014 Dec; 28(12):1016. PubMed ID: 25510801
[No Abstract] [Full Text] [Related]
2. Chemotherapy for low-grade gliomas: lessons and questions.
Raizer J
Oncology (Williston Park); 2014 Dec; 28(12):1043-4, 1051. PubMed ID: 25510804
[No Abstract] [Full Text] [Related]
3. Tailoring chemotherapy for low-grade gliomas.
Galanis E
Oncology (Williston Park); 2014 Dec; 28(12):1052, 1071. PubMed ID: 25510805
[No Abstract] [Full Text] [Related]
4. Chemotherapy for treatment of grade II gliomas.
Strowd RE; Holdhoff M; Grossman SA
Oncology (Williston Park); 2014 Dec; 28(12):1036-43. PubMed ID: 25510803
[TBL] [Abstract][Full Text] [Related]
5. On high-risk, low-grade glioma: What distinguishes high from low?
Geurts M; van den Bent MJ
Cancer; 2019 Jan; 125(2):174-176. PubMed ID: 30512190
[TBL] [Abstract][Full Text] [Related]
6. Early initiation of chemoradiation may not influence survival of high-grade gliomas.
Loureiro LVM; Malheiros SMF
J Neurooncol; 2018 Jan; 136(1):215-216. PubMed ID: 29116482
[No Abstract] [Full Text] [Related]
7. Effect of Treatment Modalities on Progression-Free Survival and Overall Survival in Molecularly Subtyped World Health Organization Grade II Diffuse Gliomas: A Systematic Review.
Ghaffari-Rafi A; Samandouras G
World Neurosurg; 2020 Jan; 133():366-380.e2. PubMed ID: 31473344
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival high for patients with low-grade gliomas.
Printz C
Cancer; 2014 Jul; 120(13):1913. PubMed ID: 24939460
[No Abstract] [Full Text] [Related]
9. Low-grade glioma.
Kumthekar P; Raizer J; Singh S
Cancer Treat Res; 2015; 163():75-87. PubMed ID: 25468226
[TBL] [Abstract][Full Text] [Related]
10. Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas -- data from the Swedish Brain Tumour Population-based Registry.
Asklund T; Malmström A; Björ O; Blomquist E; Henriksson R
Acta Oncol; 2013 Jun; 52(5):1041-3. PubMed ID: 23398620
[No Abstract] [Full Text] [Related]
11. Low-grade gliomas: introduction and overview.
Piepmeier JM; Christopher S
J Neurooncol; 1997 Aug; 34(1):1-3. PubMed ID: 9210048
[TBL] [Abstract][Full Text] [Related]
12. The inherent invasiveness of cerebral gliomas: implications for clinical management.
Laws ER; Shaffrey ME
Int J Dev Neurosci; 1999; 17(5-6):413-20. PubMed ID: 10571404
[No Abstract] [Full Text] [Related]
13. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
14. Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature.
di Russo P; Perrini P; Pasqualetti F; Meola A; Vannozzi R
Acta Neurochir (Wien); 2013 Dec; 155(12):2245-51. PubMed ID: 24105045
[TBL] [Abstract][Full Text] [Related]
15. Low Grade Gliomas in Children.
Chalil A; Ramaswamy V
J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
[TBL] [Abstract][Full Text] [Related]
16. Low grade glioma guidelines: Foreword.
Rock J
J Neurooncol; 2015 Dec; 125(3):447-8. PubMed ID: 26586151
[No Abstract] [Full Text] [Related]
17. Epithelial cell transformation sequence 2 is a potential biomarker of unfavorable survival in human gliomas.
Cheng YS; Lin C; Cheng YP; Yu YL; Tang CT; Hueng DY
Neurol India; 2014; 62(4):406-9. PubMed ID: 25237947
[TBL] [Abstract][Full Text] [Related]
18. Radical surgery in the management of low-grade and high-grade gliomas.
Rostomily RC; Keles GE; Berger MS
Baillieres Clin Neurol; 1996 Jun; 5(2):345-69. PubMed ID: 8781277
[No Abstract] [Full Text] [Related]
19. [An evidence based strategy for WHO Grade II Gliomas].
Narita Y
No Shinkei Geka; 2013 Jul; 41(7):565-81. PubMed ID: 23824347
[No Abstract] [Full Text] [Related]
20. Children <1 year show an inferior outcome when treated according to the traditional LGG treatment strategy: a report from the German multicenter trial HIT-LGG 1996 for children with low grade glioma (LGG).
Mirow C; Pietsch T; Berkefeld S; Kwiecien R; Warmuth-Metz M; Falkenstein F; Diehl B; von Hornstein S; Gnekow AK
Pediatr Blood Cancer; 2014 Mar; 61(3):457-63. PubMed ID: 24039013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
